Carvedilol Tablet, Film Coated
Product Images NDC 72789-411

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 72789-411). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Carvedilol (2c528763 Eac4 4001 A828 95a981ad29b1 01)

Chemical structure diagram of Carvedilol, showing the molecular formula with aromatic rings and functional groups consistent with the active ingredient Carvedilol.*

FDA Label Image

Carvedilol Tablets (2c528763 Eac4 4001 A828 95a981ad29b1 02)

A line graph showing percent mortality on the y-axis and months on the x-axis over a period up to 21 months. Two lines are plotted, one labeled 'Placebo' indicating a higher mortality trend, and one labeled 'Carvedilol' showing a lower mortality trend. A p-value of 0.0014 is noted on the graph, suggesting statistical significance.*

FDA Label Image

Carvedilol Tablets (2c528763 Eac4 4001 A828 95a981ad29b1 03)

A forest plot chart depicting hazard ratios with confidence intervals for various patient subgroups. The subgroups include men, women, age categories, racial groups, diabetic status, ischemic status, heart rate, systolic blood pressure, and spironolactone use. The chart visually compares these groups against a reference hazard ratio of 1.0.*

FDA Label Image

Structured Formula For Carvedilol (2c528763 Eac4 4001 A828 95a981ad29b1 04)

A line graph depicting mortality percentage over time in months for two groups: placebo and Carvedilol. The graph shows % mortality on the y-axis and months on the x-axis, with the Carvedilol group consistently exhibiting lower mortality than the placebo group over a 24-month period, including a significance value (P = 0.03).*

FDA Label Image

Structured Formula For Carvedilol (2c528763 Eac4 4001 A828 95a981ad29b1 05)

A hazard ratio chart presenting comparative risk data based on variables such as age, sex, prior treatment, medical conditions including diabetes and hypertension, and heart rate for patient groups. The chart includes plotted points with confidence intervals for multiple subgroups related to myocardial infarction, heart failure, and other cardiovascular conditions.*

FDA Label Image

72789411 Label (72789411)

Label for Carvedilol USP 3.125 mg film-coated tablets, oral dosage form, containing 90 tablets per package. The label shows the product NDC 72789-411-90 and identifies PD-Rx Pharmaceuticals, Inc. as the labeler located in Oklahoma City, OK. The packaging includes dosage instructions space and safety warnings, with lot number F24B34 and expiration date 09/2025.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.